Related Experiment Videos
Clinical evaluation of etomidate as an induction agent
Anaesthesia and Intensive Care
|May 1, 1978
Summary
Etomidate is a safe anesthetic induction agent, similar to Thiopentone, with rapid effects and recovery. While causing fewer respiratory issues than Thiopentone, Etomidate has drawbacks like injection pain and muscle activity, impacting its acceptance.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Anesthetic induction agents are crucial for surgical procedures.
- Etomidate and Thiopentone are commonly used intravenous induction agents.
- Evaluating and comparing anesthetic agents is vital for patient safety and procedural success.
Purpose of the Study:
- To compare the efficacy and safety of Etomidate versus Thiopentone as induction agents.
- To assess hemodynamic stability and respiratory effects of Etomidate.
- To determine the incidence of adverse events associated with Etomidate.
Main Methods:
- A comparative study involving 100 healthy female patients undergoing post-partum abdominal sterilization.
- Patients received epidural analgesia.
- Etomidate and Thiopentone were administered as induction agents for comparison.
Main Results:
- Etomidate demonstrated rapid onset and recovery, comparable to Thiopentone.
- Hemodynamic parameters (pulse rate, blood pressure) remained stable with Etomidate.
- Etomidate caused transient respiratory upsets but less respiratory depression than Thiopentone.
- Higher incidence of injection pain and involuntary muscular activity observed with Etomidate.
Conclusions:
- Etomidate is a safe and effective anesthetic induction agent for this patient population.
- Etomidate offers comparable efficacy to Thiopentone with improved respiratory safety.
- Adverse events like injection pain and myoclonus limit Etomidate's clinical acceptance among anesthesiologists.